Investors comparing insurers across developed and emerging markets often weigh the stability of a diversified North American franchise against the higher-growth, higher-risk profile of an Asia-focused operator. That is precisely the trade-off between Manulife Financial Corporation and Prudential plc. This stock comparison examines how these two companies differ in business model, growth drivers, recent momentum, and market positioning. It may be most relevant to investors and traders assessing geographic diversification, dividend income, and exposure to Asia's long-term insurance and savings opportunity, where both firms compete but with very different risk profiles.
Manulife Financial Corporation operates as Manulife in Canada and Asia and primarily as John Hancock in the United States, spanning life insurance, annuities, and wealth and asset management. Its earnings are well spread across segments, with Asia contributing the largest share, followed by Global Wealth and Asset Management, Canada, and the U.S.
Recent market activity has favored MFC, with the stock trading near the upper end of its 52-week range. In its latest quarterly results, core earnings per share rose double digits year over year, driven by business growth in Asia and Global WAM (Wealth and Asset Management). Annual premium equivalent (APE) sales, a key measure of new insurance business volume, climbed roughly 20%, while core return on equity (ROE) expanded above 16%. The company also announced a multi-billion-dollar risk-transfer agreement covering U.S. long-term care policies, reducing exposure to a historically volatile line. Analyst price targets have drifted higher in recent weeks, and sentiment has been supported by improving wealth-management flows and disciplined capital returns.
Prudential plc is a life and health insurer and asset manager focused on Asia and Africa, with leading positions in Hong Kong, Singapore, Malaysia, Indonesia, India, and several African markets. Its asset management arm, Eastspring, adds a fee-based business alongside insurance. The company is listed in London and Hong Kong and trades on the NYSE as an American depositary receipt (ADR).
Operationally, PUK has posted broad-based growth, with new business profit (NBP) and adjusted operating profit per share rising in the latest half-year period, and management expanding its share-buyback program while raising the interim dividend. Growth was diversified across ASEAN markets, India, and Africa. However, regulatory changes in mainland China affecting bancassurance expenses and tougher comparisons in Hong Kong have pressured parts of the business. In recent weeks the stock has traded near its 52-week low, reflecting cautious investor sentiment toward China and Hong Kong despite the company's underlying momentum and a stronger capital position following a ratings upgrade.
For traders seeking a data-driven edge in this type of stock comparison, Tickeron's Trending AI Robots page offers a curated view of the platform's AI-powered trading tools. Tickeron hosts hundreds of AI trading bots that collectively monitor thousands of different tickers, each with its own trading style, strategy, timeframe, performance record, statistics, and set of tickers it trades. Because market conditions shift, not every bot fits every moment; only the strongest and most suitable performers are featured in the Trending AI Robots section. This allows users to explore bots with differing risk profiles and approaches rather than a one-size-fits-all signal. Traders and investors interested in applying algorithmic analysis to names like MFC and PUK may find it useful to review the currently featured robots and their performance metrics.
The clearest contrast is geographic concentration. MFC spreads risk across three major regions and mixes capital-intensive insurance with a growing fee-based wealth business. PUK is a more focused, higher-beta wager on Asia's rising insurance penetration and Africa's emerging growth, with little developed-market offset.
On valuation, PUK trades at a lower P/E (price-to-earnings) ratio than MFC, while MFC offers a higher dividend yield, currently above 3% versus roughly 2% for PUK. This reflects the market's discount for PUK's regulatory and concentration risk. On momentum, MFC has held near recent highs while PUK has pulled back toward its 52-week low, even as both firms report double-digit growth in key metrics. Risk factors differ as well: MFC carries legacy long-term care and general-account investment risk, which it has been actively reinsuring away, whereas PUK faces policy shifts in China, cross-border demand swings in Hong Kong, and currency volatility across emerging markets. Sector exposure is similar, but market sentiment currently rewards MFC's diversification and capital-return visibility more than PUK's growth runway.
Based on observable trend consistency, relative stability, and near-term catalysts, Tickeron's AI would likely lean toward MFC in the current environment. MFC's steadier upward price trend, improving capital position, and active risk reduction provide a more consistent backdrop than PUK's pullback and China-related uncertainty. That said, the verdict is probabilistic rather than definitive: PUK's lower valuation, expanded buyback, and long-term growth potential in underpenetrated markets could warrant a more favorable view if sentiment toward China and Hong Kong stabilizes. The balance of observable factors presently favors MFC for trend stability, while PUK represents a higher-growth, higher-volatility alternative for investors comfortable with emerging-market concentration.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The Moving Average Convergence Divergence (MACD) for MFC turned positive on October 15, 2026. Looking at past instances where MFC's MACD turned positive, the stock continued to rise in 34 of 46 cases over the following month. The odds of a continued upward trend are 74%.
The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on MFC as a result. In 50 of 77 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 65%.
MFC moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for MFC crossed bullishly above the 50-day moving average on October 21, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 7 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 44%.
Following a +2.56% 3-day Advance, the price is estimated to grow further. Considering data from situations where MFC advanced for three days, in 223 of 350 cases, the price rose further within the following month. The odds of a continued upward trend are 64%.
The Aroon Indicator entered an Uptrend today. In 199 of 354 cases where MFC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 56%.
The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MFC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 50%.
MFC broke above its upper Bollinger Band on October 21, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Profit vs. Risk Rating rating for this company is 4 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. MFC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 51 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.609) is normal, around the industry mean (1.347). P/E Ratio (12.232) is within average values for comparable stocks, (19.840). Projected Growth (PEG Ratio) (0.876) is also within normal values, averaging (0.463). Dividend Yield (0.031) settles around the average of (0.046) among similar stocks. P/S Ratio (1.780) is also within normal values, averaging (1.303).
The Tickeron PE Growth Rating for this company is 59 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The RSI Indicator for PUK moved out of oversold territory on October 15, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 32 similar instances when the indicator left oversold territory. In 22 of the 32 cases the stock moved higher. This puts the odds of a move higher at 69%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 40 of 68 cases where PUK's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 59%.
The Momentum Indicator moved above the 0 level on October 21, 2026. You may want to consider a long position or call options on PUK as a result. In 39 of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 49%.
The Moving Average Convergence Divergence (MACD) for PUK just turned positive on October 15, 2026. Looking at past instances where PUK's MACD turned positive, the stock continued to rise in 33 of 48 cases over the following month. The odds of a continued upward trend are 69%.
Following a +2.56% 3-day Advance, the price is estimated to grow further. Considering data from situations where PUK advanced for three days, in 165 of 283 cases, the price rose further within the following month. The odds of a continued upward trend are 58%.
PUK may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PUK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 72%.
The Aroon Indicator for PUK entered a downward trend on October 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.520) is normal, around the industry mean (1.347). P/E Ratio (8.537) is within average values for comparable stocks, (19.840). PUK's Projected Growth (PEG Ratio) (2.391) is very high in comparison to the industry average of (0.463). Dividend Yield (0.028) settles around the average of (0.046) among similar stocks. P/S Ratio (1.124) is also within normal values, averaging (1.303).
The Tickeron PE Growth Rating for this company is 63 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 73 (best 1 - 100 worst), indicating slightly worse than average price growth. PUK’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PUK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock worse than average.
MFC | PUK | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 21 | 12 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 51 Fair valued | 50 Fair valued | |
PROFIT vs RISK RATING 1..100 | 4 | 100 | |
SMR RATING 1..100 | 100 | 92 | |
PRICE GROWTH RATING 1..100 | 41 | 73 | |
P/E GROWTH RATING 1..100 | 59 | 63 | |
SEASONALITY SCORE 1..100 | 85 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
PUK's Valuation (50) in the Multi Line Insurance industry is in the same range as MFC (51) in the Life Or Health Insurance industry. This means that PUK’s stock grew similarly to MFC’s over the last 12 months.
MFC's Profit vs Risk Rating (4) in the Life Or Health Insurance industry is significantly better than the same rating for PUK (100) in the Multi Line Insurance industry. This means that MFC’s stock grew significantly faster than PUK’s over the last 12 months.
PUK's SMR Rating (92) in the Multi Line Insurance industry is in the same range as MFC (100) in the Life Or Health Insurance industry. This means that PUK’s stock grew similarly to MFC’s over the last 12 months.
MFC's Price Growth Rating (41) in the Life Or Health Insurance industry is in the same range as PUK (73) in the Multi Line Insurance industry. This means that MFC’s stock grew similarly to PUK’s over the last 12 months.
MFC's P/E Growth Rating (59) in the Life Or Health Insurance industry is in the same range as PUK (63) in the Multi Line Insurance industry. This means that MFC’s stock grew similarly to PUK’s over the last 12 months.
| MFC | PUK | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 51% | 1 day ago 69% |
| Stochastic ODDS (%) | 1 day ago 44% | 1 day ago 59% |
| Momentum ODDS (%) | 1 day ago 65% | 1 day ago 49% |
| MACD ODDS (%) | 1 day ago 74% | 1 day ago 69% |
| TrendWeek ODDS (%) | 1 day ago 60% | 1 day ago 72% |
| TrendMonth ODDS (%) | 1 day ago 56% | 1 day ago 74% |
| Advances ODDS (%) | 1 day ago 64% | 2 days ago 58% |
| Declines ODDS (%) | 16 days ago 50% | 9 days ago 72% |
| BollingerBands ODDS (%) | 1 day ago 40% | 1 day ago 69% |
| Aroon ODDS (%) | 1 day ago 56% | 1 day ago 70% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
MFC’s FA Score shows that 1 FA rating(s) are green while PUK’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
MFC’s TA Score shows that 6 TA indicator(s) are bullish while PUK’s TA Score has 6 bullish TA indicator(s).
MFC (@Life/Health Insurance) experienced а +4.01% price change this week, while PUK (@Life/Health Insurance) price change was -0.21% for the same time period.
The average weekly price growth across all stocks in the @Life/Health Insurance industry was +3.54%. For the same industry, the average monthly price growth was -0.35%, and the average quarterly price growth was -1.67%.
MFC is expected to report earnings on Nov 04, 2026.
Life insurance companies mainly sell policies that pay a death benefit as a lump sum upon the death of the insured to their beneficiaries. Life insurance policies may be sold as term life, (which guarantees payment of a stated death benefit and expires at the end of a specified term) or permanent /typically whole life (which is more expensive but lasts a lifetime and carries a cash accumulation component). Life insurance firms may also sell long-term disability policies that help to replace the insured individual’s income if they become sick or disabled. Health insurance, on the other hand, helps pay for medical expenses. Anthem, Inc., MetLife, Inc. and Aflac Incorporated are some of the largest U.S. companies in this industry.